Peer-Reviewed Journal Details
Mandatory Fields
Naqvi, SM,Perez, JAP,Kumar, V,Verbruggen, ASK,McNamara, LM
2020
June
Frontiers in Bioengineering and Biotechnology
A Novel 3D Osteoblast and Osteocyte Model Revealing Changes in Mineralization and Pro-osteoclastogenic Paracrine Signaling During Estrogen Deficiency
Published
Optional Fields
estrogen deficiency osteoblasts osteocytes mineralization 3D culture mechanical stimulation MESENCHYMAL STEM-CELLS DENTIN MATRIX PROTEIN-1 FLUID SHEAR-STRESS BONE-FORMATION IN-VITRO MECHANICAL-STRESS OSTEOGENIC DIFFERENTIATION HYDROSTATIC-PRESSURE INTEGRIN EXPRESSION RECEPTOR ACTIVATOR
8
Recentin vitrostudies have revealed that the mechanobiological responses of osteoblasts and osteocytes are fundamentally impaired during estrogen deficiency. However, these two-dimensional (2D) cell culture studies do not account forin vivobiophysical cues. Thus, the objectives of this study are to (1) develop a three-dimensional (3D) osteoblast and osteocyte model integrated into a bioreactor and (2) apply this model to investigate whether estrogen deficiency leads to changes in osteoblast to osteocyte transition, mechanosensation, mineralization, and paracrine signaling associated with bone resorption by osteoclasts. MC3T3-E1s were expanded in media supplemented with estrogen (17 beta-estradiol). These cells were encapsulated in gelatin-mtgase before culture in (1) continued estrogen (E) or (2) no further estrogen supplementation. Constructs were placed in gas permeable and water impermeable cell culture bags and maintained at 5% CO(2)and 37 degrees C. These bags were either mechanically stimulated in a custom hydrostatic pressure (HP) bioreactor or maintained under static conditions (control). We report that osteocyte differentiation, characterized by the presence of dendrites and staining for osteocyte marker dentin matrix acidic phosphoprotein 1 (DMP1), was significantly greater under estrogen withdrawal (EW) compared to under continuous estrogen treatment (day 21). Mineralization [bone sialoprotein (BSP), osteopontin (OPN), alkaline phosphatase (ALP), calcium] and gene expression associated with paracrine signaling for osteoclastogenesis [receptor activator of nuclear factor kappa-beta ligand (RANKL)/osteoprotegerinOPGratio] were significantly increased in estrogen deficient and mechanically stimulated cells. Interestingly, BSP and DMP-1 were also increased at day 1 and day 21, respectively, which play a role in regulation of biomineralization. Furthermore, the increase in pro-osteoclastogenic signaling may be explained by altered mechanoresponsiveness of osteoblasts or osteocytes during EW. These findings highlight the impact of estrogen deficiency on bone cell function and provide a novelin vitromodel to investigate the mechanisms underpinning changes in bone cells after estrogen deficiency.
10.3389/fbioe.2020.00601
Grant Details
Publication Themes